Evidence map›Paper›PMID 40696625›Full record

ArticleMedicine2025

Transient abnormal myelopoiesis in a premature infant with Down syndrome: A case report.

Jin Wang, Dan Wang, Xuwei Tao, Tingting Li, Lingkong Zeng, Shi Wang

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jin WangDepartment of Neonatology, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei Province, China.ORCID 0000-0002-7378-5262
Dan Wang
Xuwei Tao
Tingting Li
Lingkong Zeng
Shi Wang

Funding

Medical Research Program of Hubei Province Pediatric Alliance HBPAMR-2021-06
6 · The paper itself

Abstract

rationaleTransient abnormal myelopoiesis with mutations in GATA1 gene can be self-alleviated after 3 to 4 months of birth in term infant, however, the premature infant with this disease in our research achieved remission earlier. PATIENT CONCERNS: A 10-hours-old girl was diagnosed with transient abnormal myelopoiesis with GATA1 mutation. DIAGNOSIS: Transient abnormal myelopoiesis in a premature infant was suspected.

interventionsThe patient received anti-infection, liver protection, hydration, and alkalization treatments for leukocytosis. OUTCOMES: After admission, the infant was diagnosed with TAM with GATA1 mutation after completing bone marrow cytology, whole-exon gene detection, and FISH detection. The GATA1 gene mutation of this baby turns negative a month later. LESSONS: Transient abnormal myelopoiesis differs from congenital leukemia. Most children can self-alleviate after 3 to 4 months of birth, and GATA1 mutation turns negative. Since some children with transient abnormal myelopoiesis may develop myeloid leukemia of Down syndrome, continuous follow-up is required once transient abnormal myelopoiesis is diagnosed for early detection and treatment.

Indexed as

Down SyndromeGATA1 Transcription FactorLeukemoid ReactionMyelopoiesisFemaleHumansInfant, NewbornInfant, PrematureMutationGATA1 protein, humanGATA1 Transcription Factorcase reportpremature infanttransient abnormal myelopoiesis

Identifiers

PMID40696625
PMCPMC12282723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.